Opinion|Videos|May 3, 2024
Overview of ESR1 Mutations in ER+/HER2- Metastatic Breast Cancer
Author(s)Stephanie L. Graff, MD
Stephanie L. Graff, MD, provides an overview of ESR1 mutations in ER+/HER2- metastatic breast cancer, highlighting their prevalence, clinical implications, and challenges.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA OKs Zidesamtinib as New Option for Resistant ROS1+ NSCLC
2
Cognitive Rehabilitation Improves Functional Outcomes in Long COVID Brain Fog
3
PMOS Linked to 4-Fold Atherosclerotic Heart Disease Risk in 2.5 Million US Women
4
CAR T-Cell Therapy Shows Promise in Refractory Myasthenia Gravis, Evidence Still Limited
5